This inventor holds 11 USPTO granted patents and 5 published patent applications and 7 EPO patents. Top assignees: Gentium S.r.l., Danisco A/s, Dupont Nutrition Biosciences Aps. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 10 
2 out of 136 
1 out of 149 
Years Active: 2011-2026
Title: Inventor Vijay Kumar: Innovating Biological Activity Assessment
Introduction
Vijay Kumar, an accomplished inventor based in Casnate, Italy, is known for his significant contributions to the field of biochemistry and pharmaceutical sciences. With a total of eight patents to his name, he has focused his research on innovative methods that enhance the understanding and application of defibrotide, a drug used in various therapeutic contexts.
Latest Patents
Among his notable achievements is the recent patent for an "Euglobulin-based method for determining the biological activity of defibrotide." This innovative method involves bringing defibrotide into contact with mammalian euglobulin and a substrate specific for plasmin. The reaction produces a measurable product, allowing for the assessment of defibrotide's biological activity. The liquid formulations of defibrotide disclosed in the patent are aimed at providing water solutions with a defined biological activity, specifically ranging from 25 to 35 IU/mg, with an optimal range from 28 to 32 IU/mg.
Career Highlights
Vijay Kumar's career has been marked by his work at prominent companies such as Gentium S.r.l. and Danisco A/S. His tenure at these organizations has allowed him to further his research and application of biotechnological innovations, particularly those related to therapeutic agents.
Collaborations
Throughout his career, Kumar has collaborated with esteemed colleagues, including Terenzio Ignoni and Khalid Islam. These partnerships have undoubtedly enriched his research endeavors and contributed to the advancement of innovative biotechnological solutions.
Conclusion
In conclusion, Vijay Kumar is a remarkable inventor whose work in developing methodologies to assess the biological activity of defibrotide has the potential to impact the pharmaceutical industry positively. His dedication to innovation and collaboration underscores the importance of continued research in the medical field, aiming for breakthroughs that can enhance treatment and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile